Compound Library

Educational summaries organized by evidence maturity, limitations, and regulatory context.

Evidence across the library

How tracked compounds distribute by human-evidence grade. Most sit in C–D — an honest picture of the peptide literature.

Browsing is free. Full evidence-graded research reports, graphs, and comparison tools are part of Vial+ ($20 one-time).

Showing 8 free-tier results

AOD-9604

C

Body Composition · Metabolic

A 16-amino-acid fragment of human growth hormone investigated for obesity, which failed multiple Phase 2 trials to demonstrate weight-loss efficacy versus placebo.

BPC-157

D

Healing · Gut

A 15-amino-acid synthetic peptide fragment derived from a gastric juice protein, widely promoted for soft-tissue healing despite an evidence base dominated by rodent studies.

Cagrilintide

B

Metabolic · Body Composition

A long-acting amylin analog under Phase 3 investigation primarily in combination with semaglutide (CagriSema) for obesity and type 2 diabetes.

Cerebrolysin

C

Neuroprotection · Nootropic

A complex mixture of peptide fragments and amino acids derived from porcine brain tissue, used clinically in many countries for stroke and dementia and characterized as a polypeptide drug rather than a single defined peptide.

CJC-1295 (DAC)

D

Growth Hormone · Endocrine

A long-acting GHRH analog conjugated to a Drug Affinity Complex for albumin binding, originally developed by ConjuChem and never advanced to Phase 3.

CJC-1295 (No DAC)

D

Growth Hormone · Endocrine

A short-acting GHRH analog stabilized by amino-acid substitutions but lacking the Drug Affinity Complex of the original ConjuChem compound.

DSIP

D

Sleep · Nootropic

A nonapeptide originally isolated from rabbit brain in 1977, proposed to influence sleep architecture and stress response, with limited and inconsistent human trial evidence.

Epitalon

D

Anti-Aging · Endocrine

A synthetic four-amino-acid peptide proposed by Russian researchers to influence pineal function and aging, with an evidence base concentrated almost entirely in one research network.